Pharma
01
Novo Nordisk partners with Anthropic to enhance AI in drug discovery and development.
02
Utilize Claude Science to address specific challenges in R&D workflows.
03
Focus on integrating AI across genomics, proteomics, and other scientific areas.
04
CEO emphasizes partnership will significantly boost R&D capabilities.
05
Financial details of the collaboration remain undisclosed.
The full story
Novo Nordisk Turns to Anthropic to Accelerate AI-Driven Drug Development